Matthew Mazdyasni - 10 Nov 2025 Form 4 Insider Report for Astrana Health, Inc. (ASTH)

Role
Director
Signature
/s/ Kathy Diep, as Attorney-in-Fact
Issuer symbol
ASTH
Transactions as of
10 Nov 2025
Net transactions value
+$364,000
Form type
4
Filing time
12 Nov 2025, 17:05:35 UTC
Previous filing
13 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mazdyasni Matthew Director C/O ASTRANA HEALTH, INC., 1668 S. GARFIELD AVE, 2ND FLOOR, ALHAMBRA /s/ Kathy Diep, as Attorney-in-Fact 12 Nov 2025 0001809915

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ASTH Common Stock Options Exercise $364,000 +20,000 +135% $18.20 34,763 10 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ASTH Stock Option (right to Buy) Options Exercise $0 -20,000 -100% $0.000000 0 10 Nov 2025 Common Stock 20,000 $18.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 6,449 shares of restricted stock, which will vest on the earlier of June 11, 2026 or the date of the Issuer's 2026 annual meeting of stockholders.
F2 These stock options were fully vested and exercisable.